Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ChimLeish, a new recombinant chimeric protein evaluated as a diagnostic and prognostic marker for visceral leishmaniasis and human immunodeficiency virus coinfection.
Galvani NC, Machado AS, Lage DP, Freitas CS, Vale DL, de Oliveira D, Ludolf F, Ramos FF, Fernandes BB, Luiz GP, Mendonça DVC, Oliveira-da-Silva JA, Reis TAR, Tavares GSV, Chaves AT, Guimarães NS, Tupinambás U, Cota GF, Humbert MV, Martins VT, Christodoulides M, Coelho EAF, Machado-de-Ávila RA. Galvani NC, et al. Among authors: tavares gsv. Parasitol Res. 2021 Dec;120(12):4037-4047. doi: 10.1007/s00436-021-07342-1. Epub 2021 Oct 19. Parasitol Res. 2021. PMID: 34664113 Free PMC article.
Antileishmanial activity and mechanism of action from a purified fraction of Zingiber officinalis Roscoe against Leishmania amazonensis.
Duarte MC, Tavares GS, Valadares DG, Lage DP, Ribeiro TG, Lage LM, Rodrigues MR, Faraco AA, Soto M, da Silva ES, Chávez Fumagalli MA, Tavares CA, Leite JP, Oliveira JS, Castilho RO, Coelho EA. Duarte MC, et al. Exp Parasitol. 2016 Jul;166:21-8. doi: 10.1016/j.exppara.2016.03.026. Epub 2016 Mar 22. Exp Parasitol. 2016. PMID: 27013260
Antigenicity, immunogenicity and protective efficacy of a conserved Leishmania hypothetical protein against visceral leishmaniasis.
Dias DS, Martins VT, Ribeiro PAF, Ramos FF, Lage DP, Tavares GSV, Mendonça DVC, Chávez-Fumagalli MA, Oliveira JS, Silva ES, Gomes DA, Rodrigues MA, Duarte MC, Galdino AS, Menezes-Souza D, Coelho EAF. Dias DS, et al. Among authors: tavares gsv. Parasitology. 2018 May;145(6):740-751. doi: 10.1017/S0031182017001731. Epub 2017 Nov 8. Parasitology. 2018. PMID: 29113597
Evaluation of a Leishmania hypothetical protein administered as DNA vaccine or recombinant protein against Leishmania infantum infection and its immunogenicity in humans.
Ribeiro PAF, Dias DS, Lage DP, Costa LE, Martins VT, Tavares GSV, Mendonça DVC, Lima MP, Oliveira JS, Steiner BT, Machado-de-Ávila RA, Roatt BM, Chávez-Fumagalli MA, Menezes-Souza D, Duarte MC, Teixeira AL, Coelho EAF. Ribeiro PAF, et al. Among authors: tavares gsv. Cell Immunol. 2018 Sep;331:67-77. doi: 10.1016/j.cellimm.2018.05.009. Epub 2018 May 29. Cell Immunol. 2018. PMID: 29871740
A Leishmania hypothetical protein-containing liposome-based formulation is highly immunogenic and induces protection against visceral leishmaniasis.
Ribeiro PAF, Dias DS, Novais MVM, Lage DP, Tavares GSV, Mendonça DVC, Oliveira JS, Chávez-Fumagalli MA, Roatt BM, Duarte MC, Menezes-Souza D, Ludolf F, Tavares CAP, Oliveira MC, Coelho EAF. Ribeiro PAF, et al. Among authors: tavares gsv, tavares cap. Cytokine. 2018 Nov;111:131-139. doi: 10.1016/j.cyto.2018.08.019. Epub 2018 Aug 22. Cytokine. 2018. PMID: 30142534
A Pluronic® F127-based polymeric micelle system containing an antileishmanial molecule is immunotherapeutic and effective in the treatment against Leishmania amazonensis infection.
Tavares GSV, Mendonça DVC, Miyazaki CK, Lage DP, Soyer TG, Carvalho LM, Ottoni FM, Dias DS, Ribeiro PAF, Antinarelli LMR, Ludolf F, Duarte MC, Coimbra ES, Chávez-Fumagalli MA, Roatt BM, Menezes-Souza D, Barichello JM, Alves RJ, Coelho EAF. Tavares GSV, et al. Parasitol Int. 2019 Feb;68(1):63-72. doi: 10.1016/j.parint.2018.10.005. Epub 2018 Oct 16. Parasitol Int. 2019. PMID: 30339837
In silico Leishmania proteome mining applied to identify drug target potential to be used to treat against visceral and tegumentary leishmaniasis.
Chávez-Fumagalli MA, Lage DP, Tavares GSV, Mendonça DVC, Dias DS, Ribeiro PAF, Ludolf F, Costa LE, Coelho VTS, Coelho EAF. Chávez-Fumagalli MA, et al. Among authors: tavares gsv. J Mol Graph Model. 2019 Mar;87:89-97. doi: 10.1016/j.jmgm.2018.11.014. Epub 2018 Nov 29. J Mol Graph Model. 2019. PMID: 30522092
In vivo antileishmanial efficacy of a naphthoquinone derivate incorporated into a Pluronic® F127-based polymeric micelle system against Leishmania amazonensis infection.
Mendonça DVC, Tavares GSV, Lage DP, Soyer TG, Carvalho LM, Dias DS, Ribeiro PAF, Ottoni FM, Antinarelli LMR, Vale DL, Ludolf F, Duarte MC, Coimbra ES, Chávez-Fumagalli MA, Roatt BM, Menezes-Souza D, Barichello JM, Alves RJ, Coelho EAF. Mendonça DVC, et al. Among authors: tavares gsv. Biomed Pharmacother. 2019 Jan;109:779-787. doi: 10.1016/j.biopha.2018.10.143. Epub 2018 Nov 5. Biomed Pharmacother. 2019. PMID: 30551531 Free article.
In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
Tavares GSV, Mendonça DVC, Lage DP, Antinarelli LMR, Soyer TG, Senna AJS, Matos GF, Dias DS, Ribeiro PAF, Batista JPT, Poletto JM, Brandão GC, Chávez-Fumagalli MA, Pereira GR, Coimbra ES, Coelho EAF. Tavares GSV, et al. Acta Trop. 2019 Mar;191:29-37. doi: 10.1016/j.actatropica.2018.12.036. Epub 2018 Dec 23. Acta Trop. 2019. PMID: 30586571
Immunogenicity and protective efficacy of a new Leishmania hypothetical protein applied as a DNA vaccine or in a recombinant form against Leishmania infantum infection.
Ribeiro PAF, Dias DS, Lage DP, Martins VT, Costa LE, Santos TTO, Ramos FF, Tavares GSV, Mendonça DVC, Ludolf F, Gomes DA, Rodrigues MA, Chávez-Fumagalli MA, Silva ES, Galdino AS, Duarte MC, Roatt BM, Menezes-Souza D, Teixeira AL, Coelho EAF. Ribeiro PAF, et al. Among authors: tavares gsv. Mol Immunol. 2019 Feb;106:108-118. doi: 10.1016/j.molimm.2018.12.025. Epub 2018 Dec 27. Mol Immunol. 2019. PMID: 30594673
63 results